Company news
Petlife Pharmaceuticals Inc (OTC:PTLF) news
Petlife Pharmaceuticals Inc news releases on 6ix. Latest, Jun 6, 2018: OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor…
Press releases & updates
OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of May
June 6, 2018
PetLife Pharmaceuticals Announces Haiti Veterinary Initiative
October 18, 2017
PetLife Pharmaceuticals Gets 'On the Road Again!' With 2 Scheduled Road Shows in California
July 30, 2017
PetLife Pharmaceuticals' CEO, Dr. Ralph Salvagno, Issues Letter to Shareholders
July 19, 2017
PetLife Announces its All-natural 'Cancer Cocktail' With Applicability to Pet and Human Markets
June 14, 2017
PetLife Completes Its TV Commercial for Newly Acquired Dr. Geoff's by PetLife, Preparing for Regional Launch
June 5, 2017
PetLife Pharmaceuticals Launches New Website
May 31, 2017
PetLife Management Comments on Recent Market Activity
May 30, 2017
PetLife Files for Patent for the Treatment of Cancer for Pets
May 29, 2017
PetLife Explores New Scorpion Venom-Based Therapies for Growing Product Line
May 25, 2017
PetLife Closes Acquisition of Assets for Dr. Geoff's Real Food for Pets
May 22, 2017
PetLife Finalizes Negotiations for Dr. Geoff’s Real Food for Pets
April 18, 2017
PetLife: Holistic Pet Health is Next Big Trend in Veterinary Medicine
April 12, 2017
PetLife: Millennial Pet Owners Leading Charge in Rapid Growth of Holistic Pet Care
March 24, 2017
PetLife Supersedes Expectations for the Acquisition of Dr. Geoff’s Real Food for Pets
March 21, 2017
PetLife Pharmaceuticals Provides an Eye-Opening View on a Recession Resistive Industry
March 7, 2017
PetLife Pharmaceuticals Signs Letter of Intent to Acquire Healthy Life Pets Brand
February 28, 2017
PetLife Pharmaceutical Taps National Public Relations Firm to Help Bring to Market Cancer Treatment Originally Developed by Cuba
February 21, 2017
World Renowned Veterinary Nutritionist Dr. R. Geoffrey Broderick Continues Groundbreaking Efforts to Help Animals by Joining PetLife Pharmaceuticals, Inc. as the Chairman of Product Development and Advisory Board
February 9, 2017
PetLife Pharmaceuticals Announces Son of World Famous Veterinarian & Pet Industry Innovator, Geoffrey Broderick, to Join the Company as the New President
February 3, 2017
PetLife Pharmaceuticals reports the First of Three Preclinical Studies in their pre-INAD Process for Vitalzul. Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions across Multiple Dosing Levels.
January 10, 2017
Correction: PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product Line
December 7, 2016
PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product Line
December 7, 2016
PetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy” While Preparing for FDA Submission
December 6, 2016
PetLife Pharmaceuticals Updates Shareholders on the Company Progress with Vitalzul™ Studies and Additional Product Offerings
December 1, 2016
PetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™
November 15, 2016
PetLife Pharmaceuticals and Lumleian, LLC Announce Partnership to Advance Development and Commercialization of Promising Veterinary Health Pipeline
October 27, 2016
PetLife Pharmaceuticals Announces the Addition of a Seasoned Marketing Specialist and Investor, Mrs. Vyvyan Campbell, to the Board of Directors
October 24, 2016
PetLife Pharmaceuticals Announces the Addition of Dr. Simon Wood PhD as the Company’s new Scientific Officer with plans to expand its Current Portfolio of Veterinarian Drugs and Nutraceuticals
October 20, 2016
PetLife Pharmaceuticals is Pleased to Announce the Completion of the New Company Website
October 17, 2016
PetLife Pharmaceuticals Expands Cell Line Study with InnoVision in Preparation for FDA/CVM Registration Submission
October 13, 2016
PetLife Pharmaceuticals is Pleased to Showcase its New “Vitalzul™ Information Video” along with a Corporate Update
October 10, 2016
PetLife Pharmaceuticals Announces pre-INAD (Investigational New Animal Drug) Cell Lines Study of Vitalzul™ has Begun
September 7, 2016
PetLife Pharmaceuticals Sees Vitalzul™ as a Major Component in the Treatment of Cancer in Pets; Releases Vitalzul™ Information and Testimonial Video
September 1, 2016
PetLife Pharmaceuticals Hires InnoVision Therapeutics in Preparation of Vitalzul™ FDA Submission
August 25, 2016
PetLife Pharmaceuticals Announces Investor Analysts Research Report
August 23, 2016
PetLife Pharmaceuticals Rebrands all Products in Preparation for The FDA Registration Process
August 19, 2016
PetLife Pharmaceuticals, Inc. Issues Letter to Shareholders
August 16, 2016
PetLife Pharmaceuticals Holds First Medical Professional Investor Conference
August 1, 2016
PetLife Pharmaceuticals Adds Seasoned Medical Professionals to the Management Team
July 25, 2016
PetLife Pharmaceuticals Retains Invicto Group as their Investor Relations Firm
July 19, 2016
OTC Markets Group Welcomes Newly Verified OTCQB Companies – January 7
January 7, 2016
PetLife Pharmaceuticals Provides Shareholder Update
March 26, 2015
PetLife to Start New Pre-Clinical Study on Escozine for Pets; Results Expected in December
October 27, 2014
PetLife Receives Initial Equity Funding Commitment for $2.5M to $5M
September 22, 2014
PetLife Publishes Two White Papers on History and Production of Escozine for Pets(TM)
September 17, 2014
OTC Markets Group Welcomes PetLife Pharmaceuticals to OTCQB
September 10, 2014
PetLife to Begin Trading Under New Ticker Symbol PTLF Monday
September 5, 2014
PetLife Issues Special Letter to Shareholders
September 3, 2014